These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7364500)

  • 1. 123I production from radioxenon formed in spallation reactions by 660 MeV protons for medical research.
    Adilbish M; Chumin VG; Khalkin VA; Knotek O; Kuznetsova MJa ; Norseev JuV ; Fominykh VI; Zaitseva NG
    Int J Appl Radiat Isot; 1980 Mar; 31(3):163-7. PubMed ID: 7364500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical uses of I-123 produced by 127I(p, 5n) 123Xe to 123I reaction in NIRS (author's transl)].
    Saegusa K; Arimizu N; Uchiyama G; Tateno Y; Rikitake T; Suzuki K; Ido T
    Kaku Igaku; 1978 Aug; 15(5):751-4. PubMed ID: 722988
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodine-122-labeled amphetamine derivative with potential for PET brain blood-flow studies.
    Mathis CA; Sargent T; Shulgin AT
    J Nucl Med; 1985 Nov; 26(11):1295-301. PubMed ID: 3877152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection in subsurface air of radioxenon released from medical isotope production.
    Johnson C; Biegalski S; Haas D; Lowrey J; Bowyer T; Hayes J; Suarez R; Ripplinger M
    J Environ Radioact; 2017 Feb; 167():160-165. PubMed ID: 27843063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere.
    Saey PR; Auer M; Becker A; Hoffmann E; Nikkinen M; Ringbom A; Tinker R; Schlosser C; Sonck M
    J Environ Radioact; 2010 Sep; 101(9):730-8. PubMed ID: 20554098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of irradiation parameters of enriched 124Xe target for 123I production in cyclotrons.
    Sumiya LC; Sciani V
    Appl Radiat Isot; 2008 Oct; 66(10):1337-40. PubMed ID: 18515122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radon removal trap design and coefficient testing for the development of an effective radioxenon sampling, separation and measurement system.
    Zhou C; Zhou G; Feng S; Zhao X; Huang D; Tian Z; Yu X; Cheng Z
    J Environ Radioact; 2019 Apr; 199-200():39-44. PubMed ID: 30684824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling with iodine-123. The reactivity of iodine-123 formed by the decay of xenon-123.
    Welch MJ
    J Am Chem Soc; 1970 Jan; 92(2):408-9. PubMed ID: 5411058
    [No Abstract]   [Full Text] [Related]  

  • 9. Excitation function for the production of 123I via the 127I(p, 5n) 123Xe reaction.
    Paans AM; Vaalburg W; Van Herk G; Woldring MG
    Int J Appl Radiat Isot; 1976 Aug; 27(8):465-7. PubMed ID: 965114
    [No Abstract]   [Full Text] [Related]  

  • 10. Abatement of xenon and iodine emissions from medical isotope production facilities.
    Doll CG; Sorensen CM; Bowyer TW; Friese JI; Hayes JC; Hoffmann E; Kephart R
    J Environ Radioact; 2014 Apr; 130():33-43. PubMed ID: 24418952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative dosimetry of 124Te(p, 2n)123I and 124Xe(p, 2m)123I.
    Maguire WJ
    Health Phys; 1989 Jul; 57(1):195-7. PubMed ID: 2745083
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of 123I as iodide by distillation.
    Qureshi MA; Mcisaac L; Schlyer D; Hupf HB; Al-Watban FA; Lewall D
    Int J Nucl Med Biol; 1985; 12(1):57-8. PubMed ID: 4008167
    [No Abstract]   [Full Text] [Related]  

  • 13. Setting the baseline for estimated background observations at IMS systems of four radioxenon isotopes in 2014.
    Gueibe C; Kalinowski MB; Baré J; Gheddou A; Krysta M; Kusmierczyk-Michulec J
    J Environ Radioact; 2017 Nov; 178-179():297-314. PubMed ID: 28942373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global radioxenon emission inventory based on nuclear power reactor reports.
    Kalinowski MB; Tuma MP
    J Environ Radioact; 2009 Jan; 100(1):58-70. PubMed ID: 19070405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad energy spectrum of laser-accelerated protons for spallation-related physics.
    McKenna P; Ledingham KW; Shimizu S; Yang JM; Robson L; McCanny T; Galy J; Magill J; Clarke RJ; Neely D; Norreys PA; Singhal RP; Krushelnick K; Wei MS
    Phys Rev Lett; 2005 Mar; 94(8):084801. PubMed ID: 15783897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclotron target for the production of radioxenons.
    Blue JW; Leonard R; Jha S; Sodd VJ; Vincent JS
    Prog Nucl Med; 1978; 4():53-60. PubMed ID: 628783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated radioxenon monitoring for the comprehensive nuclear-test-ban treaty in two distinctive locations: Ottawa and Tahiti.
    Stocki TJ; Blanchard X; D'Amours R; Ungar RK; Fontaine JP; Sohier M; Bean M; Taffary T; Racine J; Tracy BL; Brachet G; Jean M; Meyerhof D
    J Environ Radioact; 2005; 80(3):305-26. PubMed ID: 15725505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow measured by xenon-133 and [123I]iodo-amphetamine in patients with cerebrovascular diseases.
    Henriksen L; Vorstrup S; Paulson OB
    Prog Brain Res; 1984; 62():245-52. PubMed ID: 6335918
    [No Abstract]   [Full Text] [Related]  

  • 19. Isotopic noble gas signatures released from medical isotope production facilities--simulations and measurements.
    Saey PR; Bowyer TW; Ringbom A
    Appl Radiat Isot; 2010 Sep; 68(9):1846-54. PubMed ID: 20447828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Curie quantities of high purity I-123 with 15 MeV protons.
    Barrall RC; Beaver JE; Hupf HB; Rubio FF
    Eur J Nucl Med; 1981; 6(9):411-5. PubMed ID: 6268412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.